tiprankstipranks
CAMP4 Therapeutics Corporation (CAMP)
NASDAQ:CAMP
US Market
CAMP
CAMP4 Therapeutics Corporation
RESEARCH TOOLSreports
Want to see CAMP full AI Analyst Report?

CAMP4 Therapeutics Corporation (CAMP) Financial Statements

123 Followers

CAMP4 Therapeutics Corporation Financial Overview

CAMP4 Therapeutics Corporation's market cap is currently $230.52M. The company's EPS TTM is $-0.86; its P/E ratio is -2.32; CAMP4 Therapeutics Corporation is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is $-0.21. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Nov 23Feb 23Feb 22
Income Statement
Total Revenue$ 3.50M$ 652.00K$ 350.00K$ 0.00$ 295.84M
Gross Profit$ 1.86M$ 652.00K$ 350.00K$ 0.00$ 121.89M
Operating Income$ -52.06M$ -53.09M$ -51.88M$ -45.00M$ -15.31M
EBITDA$ -50.42M$ -51.39M$ -50.20M$ -44.12M$ 7.49M
Net Income$ -80.40M$ -51.79M$ -49.29M$ -44.19M$ -31.15M
Balance Sheet
Cash & Short-Term Investments$ 109.52M$ 64.04M$ 38.38M$ 83.19M$ 91.11M
Total Assets$ 117.81M$ 78.31M$ 54.95M$ 102.55M$ 402.29M
Total Debt$ 1.97M$ 8.65M$ 11.69M$ 12.39M$ 209.17M
Net Debt$ -107.54M$ -55.39M$ -26.69M$ -70.80M$ 118.05M
Total Liabilities$ 70.10M$ 15.16M$ 178.68M$ 180.08M$ 322.11M
Stockholders' Equity$ 47.70M$ 63.14M$ -123.73M$ -77.53M$ 80.18M
Cash Flow
Free Cash Flow$ -29.83M$ -46.00M$ -44.83M$ -42.57M$ -17.52M
Operating Cash Flow$ -29.55M$ -45.56M$ -44.16M$ -38.54M$ -4.22M
Investing Cash Flow$ -243.00K$ -441.00K$ -678.00K$ -4.03M$ -7.58M
Financing Cash Flow$ 75.89M$ 71.66M$ 301.00K$ 100.16M$ -2.64M
Currency in USD

CAMP4 Therapeutics Corporation Earnings and Revenue History

Income Statement >

CAMP4 Therapeutics Corporation Debt to Assets

Balance Sheet >

CAMP4 Therapeutics Corporation Cash Flow

Cash Flow >

CAMP4 Therapeutics Corporation Forecast EPS vs Actual EPS

Earnings >